tiprankstipranks
Trending News
More News >
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market

Inovio Pharmaceuticals (INO) Ratios

Compare
5,969 Followers

Inovio Pharmaceuticals Ratios

INO's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, INO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.79 2.77 3.60 3.25 6.82
Quick Ratio
0.79 2.77 3.60 3.25 6.82
Cash Ratio
0.52 1.86 0.34 0.48 1.08
Solvency Ratio
-1.36 -2.33 -2.46 -2.17 -3.11
Operating Cash Flow Ratio
-299.03 -2.95 -2.92 -2.23 -3.28
Short-Term Operating Cash Flow Coverage
-7.62K 0.00 -7.42 0.00 0.00
Net Current Asset Value
$ -21.93M$ 53.14M$ 99.51M$ 189.07M$ 352.17M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.10 0.18 0.09 0.07
Debt-to-Equity Ratio
-1.30 0.17 0.26 0.14 0.08
Debt-to-Capital Ratio
4.36 0.15 0.20 0.13 0.08
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.07 0.04
Financial Leverage Ratio
-8.99 1.65 1.46 1.57 1.24
Debt Service Coverage Ratio
-38.37 -584.52 -7.25 -216.04 -153.14
Interest Coverage Ratio
0.00 -632.05 -117.71 -213.38 -155.55
Debt to Market Cap
0.03 0.00 0.12 0.04 <0.01
Interest Debt Per Share
0.19 0.44 1.42 1.68 0.16
Net Debt to EBITDA
0.25 0.52 -0.12 0.05 0.13
Profitability Margins
Gross Profit Margin
-732.25%100.00%100.00%100.00%100.00%
EBIT Margin
-59281.69%-49172.60%-16092.90%-2693.35%-16976.28%
EBITDA Margin
-57630.57%-47735.19%-15671.81%-2639.80%-16709.72%
Operating Profit Margin
-49202.88%-51616.91%-17300.28%-2607.35%-16972.34%
Pretax Profit Margin
-59281.69%-49254.27%-16239.87%-2726.67%-17109.87%
Net Profit Margin
-59281.69%-49254.27%-16239.87%-2726.67%-17109.87%
Continuous Operations Profit Margin
-59281.69%-49254.27%-16239.87%-2726.67%-17109.87%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
120.48%95.42%93.87%104.58%100.81%
Return on Assets (ROA)
-155.79%-94.75%-79.04%-80.28%-61.23%
Return on Equity (ROE)
-307.59%-156.57%-115.14%-125.84%-75.98%
Return on Capital Employed (ROCE)
20471.67%-144.34%-112.12%-106.32%-70.02%
Return on Invested Capital (ROIC)
-3900.23%-139.85%-97.55%-105.15%-69.60%
Return on Tangible Assets
-155.79%-94.75%-79.04%-83.31%-62.90%
Earnings Yield
-132.82%-215.78%-99.57%-75.17%-2.36%
Efficiency Ratios
Receivables Turnover
0.19 0.18 0.35 0.87 0.22
Payables Turnover
0.26 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.02 0.02 0.06 0.57 0.06
Asset Turnover
<0.01 <0.01 <0.01 0.03 <0.01
Working Capital Turnover Ratio
0.06 <0.01 <0.01 0.03 <0.01
Cash Conversion Cycle
539.01 2.01K 1.06K 417.50 1.65K
Days of Sales Outstanding
1.96K 2.01K 1.06K 417.50 1.65K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
1.42K 0.00 0.00 0.00 0.00
Operating Cycle
1.96K 2.01K 1.06K 417.50 1.65K
Cash Flow Ratios
Operating Cash Flow Per Share
-400.23 -3.83 -5.61 -10.87 -1.01
Free Cash Flow Per Share
-400.23 -3.85 -5.62 -10.92 -1.01
CapEx Per Share
<0.01 0.02 0.01 0.05 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-163.99K -213.35 -387.55 -223.10 -175.23
Capital Expenditure Coverage Ratio
-163.99K -213.35 -387.55 -223.10 -175.23
Operating Cash Flow Coverage Ratio
-2.08K -8.77 -4.12 -6.74 -6.53
Operating Cash Flow to Sales Ratio
-114.51K -477.95 -149.48 -21.07 -121.54
Free Cash Flow Yield
-24975.54%-210.37%-91.88%-58.34%-1.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.75 -0.46 -1.00 -1.33 -42.32
Price-to-Sales (P/S) Ratio
458.49 228.26 163.10 36.27 7.24K
Price-to-Book (P/B) Ratio
-10.54 0.73 1.16 1.67 32.16
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -0.48 -1.09 -1.71 -59.24
Price-to-Operating Cash Flow Ratio
>-0.01 -0.48 -1.09 -1.72 -59.58
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.01 0.02 >-0.01 -1.29
Price-to-Fair Value
-10.54 0.73 1.16 1.67 32.16
Enterprise Value Multiple
-0.54 0.04 -1.16 -1.32 -43.21
Enterprise Value
57.05M -4.24M 151.60M 358.00M 12.81B
EV to EBITDA
-0.54 0.04 -1.16 -1.32 -43.21
EV to Sales
312.90 -19.49 182.21 34.88 7.22K
EV to Free Cash Flow
>-0.01 0.04 -1.22 -1.65 -59.06
EV to Operating Cash Flow
>-0.01 0.04 -1.22 -1.66 -59.40
Tangible Book Value Per Share
-0.15 2.52 5.29 10.55 1.80
Shareholders’ Equity Per Share
-0.15 2.52 5.29 11.18 1.86
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.04 0.52 <0.01
Net Income Per Share
-2.07 -3.95 -6.09 -14.07 -1.41
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.00 1.01 1.01 1.01
Research & Development to Revenue
309.73 347.27 104.18 18.29 140.44
SG&A to Revenue
47.06K 169.90 57.19 8.79 30.29
Stock-Based Compensation to Revenue
4.60K 30.29 13.31 2.20 14.84
Income Quality
0.88 0.97 0.92 0.77 0.71
Currency in USD